The pressure on businesses to become more sustainable has never been greater. Whether you are developing cosmetic ingredients, speciality chemicals, agricultural products, biomaterials, or consumer goods, the challenge is the same: how do you reduce environmental impact while remaining commercially viable?
For many SMEs and start-ups, sustainability ambitions often collide with practical realities. Raw material costs fluctuate, regulatory requirements continue to evolve, investors expect evidence of environmental responsibility, and customers increasingly demand greener products. At the same time, emerging technologies and new bio-based feedstocks are creating opportunities that were unimaginable just a decade ago.
These themes were at the heart of the York and North Yorkshire Bioeconomy Conference 2026, held at York's historic Guildhall. The event brought together researchers, manufacturers, entrepreneurs, policymakers, investors, and industry experts to explore how the UK's bioeconomy can be scaled and translated into real commercial success.
As someone who has spent more than 25 years working in formulation development, innovation, regulatory affairs, and product commercialisation, I found the conference particularly encouraging. The discussions highlighted a growing recognition that scientific innovation alone is not enough. Success requires collaboration, market understanding, regulatory readiness, and practical pathways to scale.
The bioeconomy refers to the use of renewable biological resources to produce food, materials, chemicals, energy, and consumer products. It encompasses sectors such as biotechnology, agriculture, industrial biotechnology, cosmetics, pharmaceuticals, packaging, and renewable energy.
For businesses, the bioeconomy presents opportunities to:
Many organisations still view sustainability as a compliance exercise. However, several presentations demonstrated that sustainability can also be a driver of profitability, innovation, and competitive advantage.
Examples included converting biomass into bio stimulants, transforming waste carbon into green solvents, and creating new revenue streams from anaerobic digestion facilities. Presentations showed how materials traditionally regarded as waste can become feedstocks for entirely new value chains.
This mindset is particularly relevant for manufacturers. Many companies generate by-products that could potentially be repurposed, sold, or incorporated into new formulations rather than treated solely as disposal costs.
A practical question every business should ask is:
"What resources are we currently underutilising that could create future value?"
The answer may reveal unexpected innovation opportunities.
While the science discussed was impressive, many speakers acknowledged a familiar challenge: scaling innovation.
Developing a concept in the laboratory is one thing. Producing it consistently, economically, and at commercial scale is another.
Several sessions focused on helping businesses bridge this gap, including discussions around open-access bioprocessing facilities, pilot-scale support, and commercialisation services. The message was clear: businesses do not need to solve scale-up challenges alone.
This reflects a common issue I encounter when supporting product developers and ingredient innovators. Companies often invest significant resources in R&D but underestimate the complexity of scaling formulations, validating processes, ensuring regulatory compliance, and maintaining product performance.
Early planning can significantly reduce both technical risks and commercial delays.
One of the most thought-provoking presentations asked a simple question:
"Is sustainable business still good business in 2026?"
The answer from industry leaders was largely yes, but with an important caveat.
Environmental benefits alone are rarely enough to secure adoption. Sustainable solutions must also deliver performance, functionality, reliability, or cost advantages.
This lesson applies across sectors.
For example, a bio-based ingredient may offer a lower carbon footprint, but customers will still expect performance equal to or better than conventional alternatives. Similarly, sustainable packaging must protect products effectively while remaining operationally practical.
The most successful innovations combine environmental and commercial benefits.
Another major theme was the growing influence of regulatory requirements on innovation strategies.
Industry presentations highlighted increasing pressure from UK and European legislation affecting chemicals, sustainability reporting, product design, packaging, waste management, and environmental impact.
For many SMEs, keeping pace with regulatory developments can feel overwhelming.
However, businesses that integrate regulatory considerations early in product development often gain significant advantages. They avoid costly reformulations, minimise project delays, and improve investor confidence.
In my experience, regulatory strategy works best when it is integrated into innovation planning rather than added as a final checkpoint before launch.
The conference repeatedly demonstrated the power of collaboration.
Universities, manufacturers, technology providers, innovative SMEs, and support organisations are increasingly working together to solve complex challenges.
The success stories presented throughout the day rarely involved one organisation working in isolation. Instead, they relied on partnerships that combined scientific expertise, commercial knowledge, manufacturing capability, and market insight.
This is particularly important within the bioeconomy because many innovations require expertise that spans multiple disciplines.
Businesses that actively engage with clusters, research institutions, and industry networks are often better positioned to identify opportunities, access funding, and accelerate development.
A dedicated panel discussion examined one of the sector's most pressing concerns: the skills gap.
As the bioeconomy grows, demand is increasing for professionals with expertise in biotechnology, formulation science, process engineering, sustainability, scale-up, and regulatory affairs.
Technology alone will not build the bioeconomy. Organisations also need people who understand how to translate scientific discoveries into commercially successful products.
Investing in training, knowledge transfer, and industry partnerships will be essential for businesses looking to remain competitive.
Based on the discussions throughout the conference, I would recommend five practical actions:
Small improvements implemented consistently often create significant long-term advantages.
The Bioeconomy Cluster Conference 2026 highlighted something important: the transition to a more sustainable economy is already underway. The question is no longer whether businesses should participate, but how quickly they can adapt and position themselves to benefit.
The opportunities are substantial, from bio-based ingredients and circular manufacturing models to renewable feedstocks and sustainable product innovation. However, capturing those opportunities requires more than good science. It requires practical implementation, commercial understanding, regulatory awareness, and effective collaboration.
Having spent over 25 years supporting organisations with formulation development, technical innovation, regulatory compliance, product testing, claims substantiation, and commercialisation, I understand the challenges businesses face when moving from concept to market.
If your organisation is developing sustainable products, exploring bio-based ingredients, navigating regulatory requirements, or looking to accelerate innovation, I would be happy to discuss how I can help. Get in touch to explore practical, commercially focused solutions that turn sustainable innovation into business growth.